ArticleHealth services research2006
Prescription drug expenditures and population demographics.
Article in Health services research, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system: comparing public and private prescribing.BMC health services research · 2025Article
- Main drivers of diabetes pharmaceuticals expenditures: evidence from OECD countries and Iran.Journal of diabetes and metabolic disorders · 2023Article
- Staying Ahead of the Epidemiologic Curve: Evaluation of the British Columbia Asthma Prediction System (BCAPS) During the Unprecedented 2018 Wildfire Season.Frontiers in public health · 2021Article
- Factors influencing the variation in GMS prescribing expenditure in Ireland.Health economics review · 2016Article
- An Evaluation of the British Columbia Asthma Monitoring System (BCAMS) and PM2.5 Exposure Metrics during the 2014 Forest Fire Season.International journal of environmental research and public health · 2015Article
- Estimated cost of universal public coverage of prescription drugs in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2015Article
- Association between prescribing of cardiovascular and psychotropic medications and hospital admission for falls or fractures.Drugs & aging · 2013Article
- Time series analysis of fine particulate matter and asthma reliever dispensations in populations affected by forest fires.Environmental health : a global access science source · 2013Article
- Medication deserts: survey of neighborhood disparities in availability of prescription medications.International journal of health geographics · 2012Article
- Population aging and the determinants of healthcare expenditures: the case of hospital, medical and pharmaceutical care in british columbia, 1996 to 2006.Healthcare policy = Politiques de sante · 2011Article
- Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model.British journal of clinical pharmacology · 2008Article
- Is There a Tension between Clinical Practice and Reimbursement Policy? The Case of Osteoarthritis Prescribing Practices in Ontario.Healthcare policy = Politiques de sante · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo provide detailed demographic profiles of prescription drug utilization and expenditures in order to isolate the impact of demographic change from other factors that affect drug expenditure trends. DATA SOURCES/STUDY
settingDemographic information and drug utilization data were extracted for virtually the entire British Columbia (BC) population of 1996 and 2002. All residents had public medical and hospital insurance; however their drug coverage resembled the mix of private and public insurance in the United States. STUDY
designA series of research variables were constructed to illustrate profiles of drug expenditures and drug utilization across 96 age/sex strata. DATA COLLECTION/EXTRACTION
methodsDrug use and expenditure information was extracted from the BC PharmaNet, a computer network connecting all pharmacies in the province. PRINCIPAL
findingsPer capita drug expenditures increased at an average annual rate of 10.8 percent between 1996 and 2002. Population aging explained 1.0 points of this annual rate of expenditure growth; the balance was attributable to rising age/sex-specific drug expenditures.
conclusionsRelatively little of the observed increase in drug expenditures in BC could be attributed to demographic change. Most of the expenditure increase stemmed from the age/sex-specific quantity and type of drugs purchased. The sustainability of drug spending therefore depends not on outside forces but on decisions made by policy makers, prescribers, and patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.